MANAGED CLINICAL NETWORK FOR STROKE Management of Acute Stroke Presenting Within 3 Hours of Onset of Symptoms

Size: px
Start display at page:

Download "MANAGED CLINICAL NETWORK FOR STROKE Management of Acute Stroke Presenting Within 3 Hours of Onset of Symptoms"

Transcription

1 / MANAGED CLINICAL NETWORK FOR STROKE Management of Acute Stroke Presenting Within Hours of Onset of Symptoms (For further information, contact Stroke START Page) For Clinical Advice, contact: Dr Ron MacWalter bleep Dr Alex Doney bleep 9 Consider Stroke at time of FIRST referral Given the time of onset of symptoms, and the location of the patient, could the patient have a head scan performed within hours? If YES, then seconds count, and there should be no delay. Collect all possible data on exclusion criteria (see page ) from referring source. DO NOT WAIT until YOU see the patient or until they have had a scan ROSIER Score (From history or examination) Loss of consciousness Yes - No Seizure Activity Yes - No Speech disturbance Yes + No Unilateral face weakness Yes + No Unilateral arm weakness Yes + No Unilateral leg weakness Yes + No Visual field deficit Yes + No TOTAL Total Score <: Stroke/TIA unlikely, Consider other diagnosis Date First Name Family Name CHI Address: / / (Patient label if available) Time Time of symptom onset Maximum time for commencing thrombolysis (Onset + hours) Referral source: GP ED Ward Other : : : SECONDS COUNT SECONDS COUNT SECONDS COUNT Total Score >/= : Stroke/TIA likely Resolving/Resolved Symptoms/Signs Assess need for urgent investigation as per TIA/Stroke protocol Persisting Symptoms/Signs: CONSIDER THROMBOLYSIS IF < HOURS Complete the Exclusion Criteria for Thrombolysis on Pages -. If NO absolute exclusion criteria, request immediate brain scan, inform radiologist of time-frame Inform on-call consultant (or in Ninewells, Alex Doney or Ron MacWalter 9- Mon-Fri) Take URGENT bloods for glucose (BM), FBC plus clotting / admission bloods as indicated. Ensure thrombolysis kit (Alteplase x mg vials, infusion pump, syringes and lines) available. (Available in Acute Stroke Unit Ward Ninewells) Clerk the patient using the brief form on page. Arrange appropriate high-dependency bed for transfer post-scan... HEAD SCAN RESULT Time Report: : Radiologist name... High density lesion consistent with intracranial haemorrhage.. Hypodenisty in >/ M.C.A territory or equivalent Effacement of C.S.F spaces in >/ M.C.A territory or equivalent.. Scan Contraindications to thrombolysis present? Yes No Signature No contra-indications clinically or radiologically (see page again) & still within hours Verbal consent for thrombolysis from patient.. (if not possible,may use adults with incapacity act, but discuss with duty consultant) Calculate IV bolus and infusion doses of Alteplase from chart on page... (based on actual or estimated weight) Ensure Consultant on call (or Dr Doney/MacWalter) aware of plan to proceed to thrombolysis. IV Alteplase Prescription: Signed Prepared by Given by Time commenced Alteplase bolus dose mg / Alteplase infusion mg over hour / Bolus should be administered by hand over minutes. Infusion rate is same as dose in mg, in mls/hour Transfer to high-dependency area and monitor for close neuro. and general observation.. Pg

2 CONTRA-INDICATIONS TO THROMBOLYSIS. Where cut-offs are given, clinical judgement should be exercised if a patient falls close to the cut-off. Please ensure that this list is considered at the time of first assessment, even if this assessment is by phone. ABSOLUTE CONTRA-INDICATIONS: Present Absent Symptoms beginning more than hours prior to infusion start or when time of symptom onset is unknown Known history of, or suspected intracranial haemorrhage.. Symptoms suggestive of subarachnoid haemorrhage, even if CT-scan is normal Evidence of intracranial haemorrhage (ICH) on the CT-scan Manifest or recent severe or dangerous bleeding.. Known haemorrhagic diathesis Systolic blood pressure> or diastolic BP> mm Hg, or aggressive management (IV medication) necessary to reduce BP to these limits Relative Contra-indications: Patients receiving oral anticoagulants, e.g. warfarin sodium (unless INR <.).. Administration of IV heparin within the previous hours AND an APTT exceeding the upper limit of normal.. Treatment-dose LMWH. Any history of central nervous system damage (i.e. neoplasm, aneurysm, intracranial or spinal surgery).. Recent (less than days) traumatic external heart massage, obstetric delivery Recent (less than days) puncture of a non-compressible blood-vessel (e.g. subclavian vein).. Bacterial endocarditis, pericarditis Acute pancreatitis Documented ulcerative gastrointestinal disease during the last months, oesophageal varices, arterial-aneurysm, arterial/venous malformations Neoplasm with increased bleeding risk Severe liver disease, including hepatic failure, cirrhosis, portal hypertension (oesophageal varices) and active hepatitis.. Major surgery or significant trauma in past months... Minor neurological deficit (NIHSS see page ) or symptoms rapidly improving before start of infusion. Severe stroke as assessed clinically (e.g. NIHS> see page ) and/or by appropriate imaging techniques. Pre-presentation Rankin Score, (see below) indicating significant disability, especially if due to previous stroke... Seizure at onset of stroke. Patients with any history of prior stroke and concomitant diabetes... Prior stroke within the last months Platelet count of below,/mm. Uncorrected blood glucose <. or > mmol/l. Further advice regarding contra-indications is available by contacting Dr Doney or Dr MacWalter or Stroke Registrar (or another Stroke Unit) Modified Rankin Scale (note: this is a stroke outcome scale, and should be interpreted with caution for causes of disability other than previous stroke) Score Description No symptoms at all No significant disability despite symptoms; able to carry out all usual duties and activities Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance Moderate disability; requiring some help, but able to walk without assistance Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance Severe disability; bedridden, incontinent and requiring constant nursing care and attention Dead Pg

3 a Level of Consciousness (LOC) b LOC Questions c LOC Commands. Best Gaze.Visual Fields. Facial Palsy. Best Motor RIGHT ARM. Best Motor LEFT ARM. Best Motor RIGHT LEG. Best Motor LEFT LEG 9. Limb Ataxia. Sensory. Best Language. Dysarthria. Neglect Total Score: National Institutes of Health Stroke Scale (NIHSS) Alert- keenly responsive Drowsy- rousable by minor stimulation to obey, answer, or respond Stuporous- requires repeated stimulation to attend, or is obtunded and requires strong or painful stimulation to make movements (not stereotyped) Comatose- responds only with reflex motor or autonomic effects or totally unresponsive, flaccid Answers both correctly Answers one correctly Both incorrect Patient is asked to state the month & his / her age Obeys both correctly Obeys one correctly Both incorrect Patient is asked to open & close eyes, grip & release normal hand Normal Partial gaze palsy- gaze is abnormal in one or both eyes, no forced deviation/total gaze paresis Forced deviation- or total gaze paresis not overcome by oculocephalic maneouvre No visual loss(or in a coma) partial hemianopia complete hemianopia bilateral hemianopia-including cortical blindness Normal Minor- flattened nasolabial fold, asymmetry on smiling Partial- total or near total paralysis of lower face Complete- absent facial movement in upper and lower face and lower face on one or both sides No drift- holds limb at 9 degrees for full seconds Drift- drifts down but does not hit bed Some effort against gravity No effort against gravity No movement No drift- holds limb at 9 degrees for full seconds Drift- drifts down but does not hit bed Some effort against gravity No effort against gravity No movement No drift- holds arm at degrees for full seconds Drift- drifts down but does not hit bed Some effort against gravity No effort against gravity No movement No drift- holds arm at degrees for full seconds Drift- drifts down but does not hit bed Some effort against gravity No effort against gravity No movement Absent(or in coma) Present in limb Present in or more limbs Normal Partial loss- patient feels pinprick is less sharp or is dull on affected side Dense loss(or in coma)- patient is unaware of being touched on face, arm, leg No dysphasia Mild- moderate dysphasia obvious loss of fluency or comprehension, without significant limitation on ideas expressed or form of expression. Makes conversation about provided material difficult or impossible, e.g. examiner can identify picture or naming card from patient s response. Severe dysphasia- all communication is through fragmentary expression; great need for inference, questioning, and guessing by the listener who carries burden of communication. Examiner cannot identify materials provided from patient response Mute- no usable speech or auditory comprehension, or in coma. Normal articulation Mild- moderate dysarthria- patient slurs some words can be understood with some difficulty. Unintelligible or worse- speech is so slurred as to be unintelligible (absence of or out of proportion to dyshasia) or is mute / anarthic, or in coma No neglect(or in a coma) Partial neglect- visual, tactile, auditory, spatial, or personal inattention or extinction to bilateral simultaneous stimulation in one of the sensory modalities Complete neglect- profound hemi-inattention or hemi-inattention to more than one modality. Does not recognise own hand or orients to only one side of space Pg

4 Pre-thrombolysis BRIEF clerking (full clerking to be completed once thrombolysis commenced or ruled out) Name of Assessor: History of Presenting Complaint: Relevant Past History Examination: General Blood Pressure: CNS Tone Power Sensation Notes: R Reflexes LUL RUL LLL RLL L Time of Assessment: Cranial Nerves: Relevant Drug History (especially warfarin) Allergies GCS: E / V / M / Total / SECONDS COUNT SECONDS COUNT SECONDS COUNT Signed.. Pg

5 Body Weight/ Dose Chart for Alteplase (Actilyse) mg/ml Body Weight (Kg) Approx. Body Weight (Imperial) Total rtpa dose (mg) IV Bolus % of total dose (ml) IV Infusion 9% of total dose (ml/hr) No. of mg rtpa vials required Dose Selected (Tick) st st st st st 9 st st st 9 st 9st 9st 9 9st st st 9 st9 st st 9 st9 st st st st st st 9 st 9 9 st 9 st 9 st 9 st 9 9 st 9 st 9 9 > kg, use 9 mg maximum PATIENTS MUST BE CONTINUOSLY MONITORED PRIOR TO AND DURING DRUG ADMINISTRATION and for at least hrs following administration.. Total dose:.9mgs/kg, based on actual or estimated body weight. Maximum dose is 9mgs.. Must be prescribed on front sheet of protocol, following discussion with responsible Consultant. Reconstitute mg Alteplase vial(s) with mls of Water For Injection via the transfer spike to give a solution with concentration mg/ml.. Initial % of total dose given as an IV manual push over mins administered with an experienced doctor present.. Commence pump immediately after initial bolus. Give remaining 9% of dose IV over mins via an infusion pump (If infusion dose is >ml, second syringe required) Pg

6 STROKE THROMBOLYSIS NURSING CARE PLAN DATE NEEDS/ POTENTIAL PROBLEM GOAL CARE REQUIRED DATE OF REVIEW NURSES SIGNATURE.. has had a stroke and has verbally consented for thrombolysis treatment Drug administered according to protocol and prescription -Cardiac monitoring to be commenced to monitor for early warning signs of cardiac complications -Continuous monitoring of Temperature, Pulse, Blood Pressure, Oxygen Saturation and Neuro obs require to be monitored before the administration of treatment, during and for hrs after treatment. ( Notify medics if systolic BP> mmhg or <ommhg, or diastolic > or < for readings - mins apart) Potential risk of haemorrhage due to the treatment Early detection and treatment of any adverse reactions and side effects -Report any clinically significant changes in neuro or vital signs -Report any signs of bleeding immediately -Follow algorithm for Intracranial Haemorrhage if suspected -Bed rest for hrs following the procedure -Avoid central venous access, arterial puncture and injections for the first hrs -Avoid naso-gastric tube insertion for hrs -Do NOT give drug prescriptions for anti-coagulants, anti-platelets and non steroidal anti-inflammatories for hrs -Avoid the insertion of urinary catheters for minutes prior to the procedure and for hrs after Promote cerebral perfusion and reduce intracranial pressure To minimise complications / maintain levels of cerebral perfusion -Bed rest for hrs following the procedure -Position with head up to an angle of degrees -Maintain oxygen saturation level at >9% May develop headache post treatment To minimise post stroke pain -Position to at degree angle to promote cerebral perfusion -Give analgesia to relieve symptoms (no NSAID) Unable to maintain adequate fluid intake To maintain hydration levels -Determine with medical staff IV fluid regime -Monitor and maintain fluid input and output Notes (Medical/Nursing) Date & Time Pg

7 Information to give to patients / relatives before administration of Alteplase If the criteria above are met then Alteplase is a licensed treatment for acute ischaemic stroke and so written consent is not required. If possible there should be agreement from the patient and / or relative. When the patient cannot agree because of their impairments and no relative is available, then treatment can still be given if it is judged to be in the best interests of the patient. Any explanation should include: There has been a significant stroke cause by a blocked artery preventing blood from getting to a part of the brain and causing permanent damage. With or without treatment there may be some recovery or things could get worse. Stroke is fatal in about a third of people. Only one treatment has been shown to prevent damage to the brain. This treatment, alteplase, dissolves the blood clot blocking the artery and allows blood to get back to the brain. It only proven to work if given within hours of the stroke starting There is a risk that the treatment will cause bleeding in the brain, causing a worsening stroke. This occurs in out of patients treated and is fatal in of these. Despite this, overall the treatment is much more likely to help than to cause harm. Without treatment of people with a stroke, will survive with minimal or no disability with treatment of people with a stroke, will survive with minimal disability Administration of alteplase (Actilyse ). The dosage is.9 mg/kg (maximum dose 9 mg).. % of the dose is given as bolus over minute (use a small syringe and flush). Write drug kardex.. 9% of the dose given as an infusion over hour (start as soon as bolus given). Write drug kardex.. Start the Observation chart.. Do NOT give aspirin, dipyridamole, clopidogrel or heparin. Hand-over to Medical Registrar if required. Medical Review at Hours: Time of review: Pulse: Blood pressure: / Sats: Level of Consciousness (AVPU)? Document any early problems with neurological condition, bleeding, blood pressure or saturations AND action taken. Will require further review and CT (or MRI) scan at hours + Continue documentation on Stroke Pathway Specific issues requiring immediate action Continue observations as per protocol for hours Keep BP less than / for hours Swallow assessment Hydration (in view of ability to swallow) Avoid NG tube for hours TED stockings if continuing hemiparesis Do not give aspirin, dipyridamole, clopidogrel or heparin Specific issues requiring deferred action Start aspirin at hours IF no haemorrhagic change on second CT Pg

8 Notes (Medical/Nursing) Date & Time Pg

Managed Clinical Network for Stroke Stroke Unit Protocol/Guideline

Managed Clinical Network for Stroke Stroke Unit Protocol/Guideline Managed Clinical Network for Stroke Stroke Unit Protocol/Guideline ROSIER Score (from history or examination) Loss of consciousness: Yes: -1 No: 0 Seizure activity: Yes: -1 No: 0 Is there a new acute onset

More information

Interval: [ ] Baseline [ ] 2 hours post treatment [ ] 24 hours post onset of symptoms ±20 minutes [ ] 7-10 days [ ] 3 months [ ] Other ( )

Interval: [ ] Baseline [ ] 2 hours post treatment [ ] 24 hours post onset of symptoms ±20 minutes [ ] 7-10 days [ ] 3 months [ ] Other ( ) Patient Identification. - - Pt. Date of Birth / / Hospital ( - ) Date of Exam / / Interval: [ ] Baseline [ ] 2 hours post treatment [ ] 24 hours post onset of symptoms ±20 minutes [ ] 7-10 days [ ] 3 months

More information

REHABILITATION STANDARD: COMMUNICATION

REHABILITATION STANDARD: COMMUNICATION REHABILITATION STANDARD: COMMUNICATION Residents of Vancouver Island Health Authority (VIHA) will have reasonable access to consistent, integrated, measurable, evidence based rehabilitation services. This

More information

Acute Myocardial Infarction (the formulary thrombolytic for AMI at AAMC is TNK, please see the TNK monograph in this manual for information)

Acute Myocardial Infarction (the formulary thrombolytic for AMI at AAMC is TNK, please see the TNK monograph in this manual for information) ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY Guidelines for Use of Intravenous Alteplase (Tissue Plasminogen Activator (t-pa)), Activase in the Treatment

More information

UMHS In-Patient Acute Ischemic Stroke Treatment Guidelines*

UMHS In-Patient Acute Ischemic Stroke Treatment Guidelines* Page 1 UMHS In-Patient Acute Ischemic Stroke Treatment Guidelines* Table of Contents 1) Physician Acute Stroke Checklist 2-3 2) Nursing Orders for Initial Evaluation of Patients with Acute Stroke 3) tpa

More information

IF ANY ITEM IS LEFT UNTESTED, A DETAILED EXPLANATION MUST BE CLEARLY WRITTEN ON THE FORM.

IF ANY ITEM IS LEFT UNTESTED, A DETAILED EXPLANATION MUST BE CLEARLY WRITTEN ON THE FORM. NIH Stroke Scale The NINDS tpa Stroke Trial No. - - Pt. Date of Birth / / Hospital ( - ) Date of Exam / / Interval: 1 Baseline 2 2 hours post treatment 3 24 hours post onset of symptoms 6 minutes 4 7 10

More information

Stroke Receiving Facility Toolkit

Stroke Receiving Facility Toolkit Stroke Receiving Facility Toolkit Revised June 2010 Utah State Stroke System Stroke Receiving Facility A Utah State Stroke System Toolkit Table of Contents Becoming a Stroke Receiving Facility Why Become

More information

S9 Administer thrombolytic treatment in acute ischaemic stroke

S9 Administer thrombolytic treatment in acute ischaemic stroke S9 Administer thrombolytic treatment in acute ischaemic Screening and initiating treatment, overseeing competency of treatment About this workforce competence This competence is about the emergency administration

More information

DIAGNOSTIC CRITERIA OF STROKE

DIAGNOSTIC CRITERIA OF STROKE DIAGNOSTIC CRITERIA OF STROKE Diagnostic criteria are used to validate clinical diagnoses. Here below MONICA diagnostic criteria are reported. MONICA - MONItoring trends and determinants of CArdiovascular

More information

Providence Brain Institute Providence Portland Medical Center

Providence Brain Institute Providence Portland Medical Center NIH Stroke Scale In Plain English Sandy Dancer, RN, MSN, ANP-C Sandy Dancer, RN, MSN, ANP C Providence Brain Institute Providence Portland Medical Center I have no conflicts of interest to disclose. Preferred

More information

Stroke Thrombolysis Awareness. Initial patient assessment. Using F.A.S.T., Rosier, & NIHSS Tools

Stroke Thrombolysis Awareness. Initial patient assessment. Using F.A.S.T., Rosier, & NIHSS Tools Stroke Thrombolysis Awareness Initial patient assessment Using F.A.S.T., Rosier, & NIHSS Tools Adapted from 5 Acute Trusts - 6 Primary Care Trusts Ambulance Trust 4 Local Authorities Aims Improve recognition

More information

UPDATED INCLUSION AND EXCLUSION CRITERIA FOR IV TPA ADMINISTRATION ACUTE STROKE TREATMENT: AN UPDATE GOALS OF TALK

UPDATED INCLUSION AND EXCLUSION CRITERIA FOR IV TPA ADMINISTRATION ACUTE STROKE TREATMENT: AN UPDATE GOALS OF TALK ACUTE STROKE TREATMENT: AN UPDATE James M. Gebel MD MS FAHA Medical Director Akron General Medical Center Cerebrovascular Center GOALS OF TALK Review changes to IV tpa administration as per new 2013 AHA

More information

Ischaemic stroke 85% (85 in every 100 strokes)

Ischaemic stroke 85% (85 in every 100 strokes) UNDERSTANDING STROKE DUE TO INTRACEREBRAL HAEMORRHAGE This factsheet provides information for people who have had a stroke due to an intracerebral (bleed in the brain) and for their families and carers.

More information

Care Pathway for the Administration of Intravenous Iron Sucrose (Venofer )

Care Pathway for the Administration of Intravenous Iron Sucrose (Venofer ) Departments of Haematology, Nephrology and Pharmacy Care Pathway for the Administration of Intravenous Iron Sucrose (Venofer ) [Care Pathway Review Date] Guidance for use This Care Pathway is intended

More information

TPA, STROKE, & TELEMEDICINE. Improving utilization and improving outcomes in a constantly evolving field

TPA, STROKE, & TELEMEDICINE. Improving utilization and improving outcomes in a constantly evolving field TPA, STROKE, & TELEMEDICINE Improving utilization and improving outcomes in a constantly evolving field OVERVIEW tpa inclusion and exclusion evolution Challenges to tpa administration Target:Stroke Telemedicine

More information

Patient Group Direction Hospital: Bristol Royal Infirmary Department: UHBristol Thrombosis Service University Hospitals Bristol NHS Foundation Trust.

Patient Group Direction Hospital: Bristol Royal Infirmary Department: UHBristol Thrombosis Service University Hospitals Bristol NHS Foundation Trust. Patient Group Direction Hospital: Bristol Royal Infirmary Department: UHBristol Thrombosis Service University Hospitals Bristol NHS Foundation Trust. This Patient Group Direction (PGD) has been written

More information

NIH Stroke Scale. Upon completion of this course, the nurse will understand the following principles:

NIH Stroke Scale. Upon completion of this course, the nurse will understand the following principles: NIHSS 1 NIH Stroke Scale Stroke is the third leading cause of death in the United States and cause more serious long-term disabilities than any other disease. Forty-five percent of all Medicare dollars

More information

STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE

STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE CASE REPORT: ACUTE STROKE MANAGEMENT 90 YEAR OLD WOMAN, PREVIOUSLY ACTIVE AND INDEPENDENT, CHRONIC ATRIAL FIBRILLATION,

More information

STROKE THROMBOLYSIS GUIDELINE (EMERGENCY DEPARTMENT RUN SERVICE)

STROKE THROMBOLYSIS GUIDELINE (EMERGENCY DEPARTMENT RUN SERVICE) STROKE THROMBOLYSIS GUIDELINE (EMERGENCY DEPARTMENT RUN SERVICE) 1. Aim/Purpose of this Guideline To deliver safe and effective thrombolysis for acute ischaemic stroke using robust evidence based clinical

More information

Code Stroke: Early Recognition and Emergency Management of the Acute Stroke Patient

Code Stroke: Early Recognition and Emergency Management of the Acute Stroke Patient Code Stroke: Early Recognition and Emergency Management of the Acute Stroke Patient Ali Grubbs, RN BSN Clinical Staff Leader VUMC Adult Emergency Department Vanderbilt Adult Emergency Department Patient

More information

Enoxaparin for long term anticoagulation in patients unsuitable for oral anticoagulants

Enoxaparin for long term anticoagulation in patients unsuitable for oral anticoagulants Enoxaparin for long term anticoagulation in patients unsuitable for oral anticoagulants Traffic light classification- Amber 2 Information sheet for Primary Care Prescribers Relevant Licensed Indications

More information

Stroke Care First week

Stroke Care First week Stroke Care First week Florence Nightingale (1820 1910) Stroke Unit Dedicated personnel trained in stroke management Stepwise guidelines supported by explicit checklists Continuous monitoring available

More information

Head Injury. Dr Sally McCarthy Medical Director ECI

Head Injury. Dr Sally McCarthy Medical Director ECI Head Injury Dr Sally McCarthy Medical Director ECI Head injury in the emergency department A common presentation 80% Mild Head Injury = GCS 14 15 10% Moderate Head Injury = GCS 9 13 10% Severe Head Injury

More information

Therapeutic Management Options for. Acute Ischemic Stroke Anna Rosenbaum, MD

Therapeutic Management Options for. Acute Ischemic Stroke Anna Rosenbaum, MD Therapeutic Management Options for Acute Ischemic Stroke Anna Rosenbaum, MD Epidemiology Epidemiology 4 th leading cause of death in the United States 1 Leading cause of disability Increase in projected

More information

RGN JOY LAUDE WATFORD GENERAL HOSPITAL, ENGLAND

RGN JOY LAUDE WATFORD GENERAL HOSPITAL, ENGLAND RGN JOY LAUDE WATFORD GENERAL HOSPITAL, ENGLAND Monitor patient on the ward to detect trends in vital signs and to manage accordingly To recognise deteriorating trends and request relevant medical/out

More information

Myelogram PROCEDURAL CONSENT FORM. A. Interpreter / cultural needs. B. Procedure. C. Risks of the procedure

Myelogram PROCEDURAL CONSENT FORM. A. Interpreter / cultural needs. B. Procedure. C. Risks of the procedure DO NOT WRITE IN THIS BINDING MARGIN v5.00-03/2011 SW9263 Facility: A. Interpreter / cultural needs An Interpreter Service is required? Yes No If Yes, is a qualified Interpreter present? Yes No A Cultural

More information

Patient Sticker Multiple Sclerosis Ambulatory Emergency Care Pathway

Patient Sticker Multiple Sclerosis Ambulatory Emergency Care Pathway Multiple Sclerosis Ambulatory Emergency Care Pathway 1 Consultant: Dr M Oldfield Consultant: Dr D Harris Lead Nurse: Catie Paterson Ambulatory Emergency Care (AEC) Unit Patient From ED (Emergency Department)

More information

Global Objectives. Use of the NIH Stroke Scale (NIHSS) in Emergency Department Patients with Acute Stroke. Why Do This Exercise? Session Objectives

Global Objectives. Use of the NIH Stroke Scale (NIHSS) in Emergency Department Patients with Acute Stroke. Why Do This Exercise? Session Objectives 1 Use of the NIH Scale (NIHSS) in Emergency Department Patients with Acute Professor Department of Emergency Medicine University of Illinois College of Medicine Chicago, IL Global Objectives Improve pt

More information

To outline nursing management of patients receiving epidural anesthesia during labor (Includes walking epidurals and combined spinal-epidurals).

To outline nursing management of patients receiving epidural anesthesia during labor (Includes walking epidurals and combined spinal-epidurals). HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER LABOR: EPIDURAL EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES APPROVED BY APPLIES

More information

POAC CLINICAL GUIDELINE

POAC CLINICAL GUIDELINE POAC CLINICAL GUIDELINE Acute Pylonephritis DIAGNOSIS COMPLICATED PYELONEPHRITIS EXCLUSION CRITERIA: Male Known or suspected renal impairment (egfr < 60) Abnormality of renal tract Known or suspected renal

More information

Lothian Diabetes Handbook MANAGEMENT OF DIABETIC KETOACIDOSIS

Lothian Diabetes Handbook MANAGEMENT OF DIABETIC KETOACIDOSIS MANAGEMENT OF DIABETIC KETOACIDOSIS 90 MANAGEMENT OF DIABETIC KETOACIDOSIS Diagnosis elevated plasma and/or urinary ketones metabolic acidosis (raised H + /low serum bicarbonate) Remember that hyperglycaemia,

More information

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic. Diabetic ketoacidosis in children and young people bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They

More information

Developing a Dynamic Team Approach to Stroke Care. Emergency Medical Services 2015

Developing a Dynamic Team Approach to Stroke Care. Emergency Medical Services 2015 Developing a Dynamic Team Approach to Stroke Care Emergency Medical Services 2015 Why Stroke, Why now? A recent study showed that 80 percent of people in the United States live within an hour s drive of

More information

New England Pain Management Consultants At New England Baptist Hospital

New England Pain Management Consultants At New England Baptist Hospital New England Pain Management Consultants At New England Baptist Hospital Pain Management Center Health Assessment Dear New Pain Management Patient, Welcome to the New England Pain Management Consultants

More information

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) Key priorities Identification and diagnosis Treatment for persistent AF Treatment for permanent AF Antithrombotic

More information

REGIONAL SUSPECTED STROKE PROTOCOL

REGIONAL SUSPECTED STROKE PROTOCOL 1. Stroke refers to any spontaneous damage to the brain caused by an abnormality of the blood supply by means of a clot or bleed. Strokes should be treated emergently. During a stroke, up to 2 million

More information

Acute Stroke Diagnosis and Management

Acute Stroke Diagnosis and Management Acute Stroke Diagnosis and Management Dr Gemma Smith (Specialty Trainee in Elderly Care and Stroke Medicine) Correspondence - Gemma Smith: gem.eaton@gmail.com ABSTRACT Stroke (noun): a sudden disabling

More information

Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.

Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach. Inpatient Anticoagulation Safety Purpose: Policy: To provide safe and effective anticoagulation therapy through a collaborative approach. Upon the written order of a physician, Heparin, Low Molecular Weight

More information

Planning: Patient Goals and Expected Outcomes The patient will: Remain free of unusual bleeding Maintain effective tissue perfusion Implementation

Planning: Patient Goals and Expected Outcomes The patient will: Remain free of unusual bleeding Maintain effective tissue perfusion Implementation Obtain complete heath history including allergies, drug history and possible drug Assess baseline coagulation studies and CBC Assess for history of bleeding disorders, GI bleeding, cerebral bleed, recent

More information

STROKE SERIES SS10. Understanding thrombolysis treatment For stroke

STROKE SERIES SS10. Understanding thrombolysis treatment For stroke STROKE SERIES SS10 Understanding thrombolysis treatment For stroke Chest Heart & Stroke Scotland improves the quality of life for people in Scotland affected by chest, heart and stroke illness, through

More information

GRASP-AF Coming to a PCT near you.

GRASP-AF Coming to a PCT near you. GRASP-AF Coming to a PCT near you. ADAS Anticoagulation dosing advisory service Blackpool Teaching Hospitals Trust Sean O'Brien; Anticoagulation Specialist BMS Grasp-AF and the implications on our Anticoagulation

More information

Guidelines for diagnosis and management of acute pulmonary embolism

Guidelines for diagnosis and management of acute pulmonary embolism Guidelines for diagnosis and management of acute pulmonary embolism By Dr. Ahmed Zaghloul M.D. Anesthesia & Critical Care 2014 Predisposing factors for VTE Predisposing factor Strong predisposing factors

More information

The Clinical Evaluation of the Comatose Patient in the Emergency Department

The Clinical Evaluation of the Comatose Patient in the Emergency Department The Clinical Evaluation of the Comatose Patient in the Emergency Department patients with altered mental status (AMS) and coma. treat patients who present to the Emergency Department with altered mental

More information

Level III Stroke Center Data Collection Requirements

Level III Stroke Center Data Collection Requirements Who? Level III Stroke Center Data Collection Requirements All LERN Level III Stroke Centers. LERN Level I and II Stroke Centers have reporting requirements to The Joint Commission or other Board approved

More information

All Wales Risk/Benefit Assessment Tool for Oral Anticoagulant Treatment in People with Atrial Fibrillation

All Wales Risk/Benefit Assessment Tool for Oral Anticoagulant Treatment in People with Atrial Fibrillation All Wales Risk/Benefit Assessment Tool for Oral Anticoagulant Treatment in People with Atrial Fibrillation October 2013 This report has been prepared by a multiprofessional collaborative group, with support

More information

HEAD INJURY Discharge Instructions

HEAD INJURY Discharge Instructions Hospital Copy NEUROSURGICAL CONSULTANTS, INC. www.neurosurgical-consult.com MICHAEL GIEGER, ABNS MICHAEL H. FREED, M.D., FACS, ABNS MARC H. FRIEDBERG, M.D., Ph.D., FACS, ABNS LINDEN BUILDING FIRST FLOOR

More information

GP workshop. Maria Fitzpatrick Nurse Consultant Kings College Stroke Centre

GP workshop. Maria Fitzpatrick Nurse Consultant Kings College Stroke Centre GP workshop Maria Fitzpatrick Nurse Consultant Kings College Stroke Centre Stroke: the Facts Stroke: the Facts Every 5 minutes someone in the UK has a stroke 1 in 4 men and 1 in 5 women will have a stroke

More information

SCRN Medication Review. Susan M. Gaunt MS APRN ACNS-BC CCRN CNRN Gwinnett Medical Center

SCRN Medication Review. Susan M. Gaunt MS APRN ACNS-BC CCRN CNRN Gwinnett Medical Center SCRN Medication Review Susan M. Gaunt MS APRN ACNS-BC CCRN CNRN Gwinnett Medical Center Objectives To explain the indications, contraindications, interaction, timing, dosing, side effects of: Thrombolytics

More information

STROKE OCCURRENCE SYMPTOMS OF STROKE

STROKE OCCURRENCE SYMPTOMS OF STROKE STROKE OCCURRENCE SYMPTOMS OF STROKE The symptoms of stroke depend on what part of the brain is affected and how large an area is involved. A stroke is a sudden event accompanied by one or more of the

More information

ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY

ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY Care Pathway Triage category ATRIAL FIBRILLATION PATHWAY ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY AF/ FLUTTER IS PRIMARY REASON FOR PRESENTATION YES NO ONSET SYMPTOMS OF AF./../ TIME DURATION OF AF

More information

Having denervation of the renal arteries for treatment of high blood pressure

Having denervation of the renal arteries for treatment of high blood pressure Having denervation of the renal arteries for treatment of high blood pressure The aim of this information sheet is to help answer some of the questions you may have about having denervation of the renal

More information

IVC Filter Insertion PROCEDURAL CONSENT FORM. A. Interpreter / cultural needs. B. Procedure. C. Risks of the procedure

IVC Filter Insertion PROCEDURAL CONSENT FORM. A. Interpreter / cultural needs. B. Procedure. C. Risks of the procedure DO NOT WRITE IN THIS BINDING MARGIN V4.00-03/2011 SW9264 Facility: A. Interpreter / cultural needs An Interpreter Service is required? Yes No If Yes, is a qualified Interpreter present? Yes No A Cultural

More information

Epidural Continuous Infusion. Patient information Leaflet

Epidural Continuous Infusion. Patient information Leaflet Epidural Continuous Infusion Patient information Leaflet April 2015 Introduction You may already know that epidural s are often used to treat pain during childbirth. This same technique can also used as

More information

PHYSICIAN ORDERS TRANSIENT ISCHEMIC ATTACK (TIA) OBSERVATION

PHYSICIAN ORDERS TRANSIENT ISCHEMIC ATTACK (TIA) OBSERVATION SCREENING- ABCD-2 Score The ABCD2 score is a risk assessment tool designed to improve the prediction of short-term stroke risk after a transient ischemic attack (TIA). Higher ABCD2 scores are associated

More information

patient group direction

patient group direction DICLOFENAC v01 1/8 DICLOFENAC PGD Details Version 1.0 Legal category Staff grades Approved by POM Paramedic (Non-ECP) Nurse (Non-ECP) Emergency Care Practitioner (Paramedic) Emergency Care Practitioner

More information

Stroke Reperfusion Therapy: IV t-pa Treatment Phase

Stroke Reperfusion Therapy: IV t-pa Treatment Phase Stroke Reperfusion Therapy: IV t-pa Treatment Phase IV tpa Administration for Adult Patients Arriving Within 3 Hours. Page Contents Consent Form Indications for IV tpa Contraindications Warnings t-pa Dosing

More information

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG MED Hospitalist Stroke-TIA Vital Signs Vital Signs Q4H (DEF)* Q2H Q1H Vital Signs Orthostatic Activity Activity Bedrest, for 12 hours then Up ad lib (DEF)* Bedrest, for 24 hours then Up ad lib Up Ad Lib

More information

Listen to Your Heart. What Everyone Needs To Know About Atrial Fibrillation & Stroke. The S-ICD System. The protection you need

Listen to Your Heart. What Everyone Needs To Know About Atrial Fibrillation & Stroke. The S-ICD System. The protection you need Listen to Your Heart The S-ICD System What Everyone Needs To Know About Atrial Fibrillation & Stroke The protection you need without Stroke. touching Are you your at heart risk? Increase your knowledge.

More information

Making the Case for CPG s Jean Luciano, MSN, RN, CNRN, SCRN, CRNP, FAHA Claranne Mathiesen, MSN, RN, CNRN, SCRN, FAHA

Making the Case for CPG s Jean Luciano, MSN, RN, CNRN, SCRN, CRNP, FAHA Claranne Mathiesen, MSN, RN, CNRN, SCRN, FAHA Making the Case for CPG s Jean Luciano, MSN, RN, CNRN, SCRN, CRNP, FAHA Claranne Mathiesen, MSN, RN, CNRN, SCRN, FAHA Disclosures Jeanie Luciano Genentech speakers bureau Claranne Mathiesen - none 1 Objective

More information

Prescriber Guide. 20mg. 15mg. Simply Protecting More Patients. Simply Protecting More Patients

Prescriber Guide. 20mg. 15mg. Simply Protecting More Patients. Simply Protecting More Patients Prescriber Guide 20mg Simply Protecting More Patients 15mg Simply Protecting More Patients 1 Dear Doctor, This prescriber guide was produced by Bayer Israel in cooperation with the Ministry of Health as

More information

Jeopardy Topics: THE CLOT STOPS HERE (anticoagulants) SUGAR, SUGAR, HOW D YOU GET SO HIGH (insulins)

Jeopardy Topics: THE CLOT STOPS HERE (anticoagulants) SUGAR, SUGAR, HOW D YOU GET SO HIGH (insulins) Jeopardy Topics: THE CLOT STOPS HERE (anticoagulants) SUGAR, SUGAR, HOW D YOU GET SO HIGH (insulins) I HEAR YA KNOCKING BUT YOU CAN T COME IN (electrolytes) TAKE MY BREATH AWAY (Opiates-morphine) OUT WITH

More information

4.2 Spinal Cord Compression

4.2 Spinal Cord Compression 4.2 Spinal Cord Compression AO Protocol Name: Metastatic Spinal Cord Compression (MSCC) AO Type: Type I (New Cancer), Type III (Cancer Complication) Author: ST Introduction: MSCC can cause irreversible

More information

DISCHARGE CRITERIA FOR PHASE I & II- POST ANESTHESIA CARE

DISCHARGE CRITERIA FOR PHASE I & II- POST ANESTHESIA CARE REFERENCES: The Joint Commission Accreditation Manual for Hospitals American Society of Post Anesthesia Nurses: Standards of Post Anesthesia Nursing Practice (1991, 2002). RELATED DOCUMENTS: SHC Administrative

More information

Types of Brain Injury

Types of Brain Injury Types of Brain Injury The bones of your skull are hard and they protect your brain. Your brain is soft, like firm Jell-O. When your head moves, your brain moves inside your skull. When your head is hit

More information

PICC- Peripherally Inserted Central Catheter PROCEDURAL CONSENT FORM. A. Interpreter / cultural needs. B. Procedure. C. Risks of the procedure

PICC- Peripherally Inserted Central Catheter PROCEDURAL CONSENT FORM. A. Interpreter / cultural needs. B. Procedure. C. Risks of the procedure DO NOT WRITE IN THIS BINDING MARGIN v3.00-03/2011 SW9266 Facility: PICC- Peripherally Inserted Central Catheter A. Interpreter / cultural needs An Interpreter Service is required? Yes No If Yes, is a qualified

More information

What You Should Know About Cerebral Aneurysms

What You Should Know About Cerebral Aneurysms What You Should Know About Cerebral Aneurysms From the Cerebrovascular Imaging and Interventions Committee of the American Heart Association Cardiovascular Radiology Council Randall T. Higashida, M.D.,

More information

Atrial fibrillation: medicines to help reduce your risk of a stroke what are the options?

Atrial fibrillation: medicines to help reduce your risk of a stroke what are the options? Patient decision aid Atrial fibrillation: medicines to help reduce your risk of a stroke what are the options? http://guidance.nice.org.uk/cg180/patientdecisionaid/pdf/english Published: June 2014 About

More information

Cerebral Palsy. In order to function, the brain needs a continuous supply of oxygen.

Cerebral Palsy. In order to function, the brain needs a continuous supply of oxygen. Cerebral Palsy Introduction Cerebral palsy, or CP, can cause serious neurological symptoms in children. Up to 5000 children in the United States are diagnosed with cerebral palsy every year. This reference

More information

Trust Guideline for Thromboprophylaxis in Trauma and Orthopaedic Inpatients

Trust Guideline for Thromboprophylaxis in Trauma and Orthopaedic Inpatients A clinical guideline recommended for use In: By: For: Key words: Department of Orthopaedics, NNUHT Medical staff Trauma & Orthopaedic Inpatients Deep vein thrombosis, Thromboprophylaxis, Orthopaedic Surgery

More information

Epidurals for pain relief after surgery

Epidurals for pain relief after surgery Epidurals for pain relief after surgery This information leaflet is for anyone who may benefit from an epidural for pain relief after surgery. We hope it will help you to ask questions and direct you to

More information

Femoral artery bypass graft (Including femoral crossover graft)

Femoral artery bypass graft (Including femoral crossover graft) Femoral artery bypass graft (Including femoral crossover graft) Why do I need the operation? You have a blockage or narrowing of the arteries supplying blood to your leg. This reduces the blood flow to

More information

Blood Pressure Assessment Program Screening Guidelines

Blood Pressure Assessment Program Screening Guidelines Blood Pressure Assessment Program Screening Guidelines Assessment Pre-Assessment Prior to/during assessment, explain to client the following: What is meant by high blood pressure; What are the effects

More information

PATIENT INFORMATION BOOKLET

PATIENT INFORMATION BOOKLET PATIENT INFORMATION BOOKLET Wingspan Stent System with Gateway PTA Balloon Catheter TABLE OF CONTENTS Definitions... 2 What is the Purpose of This Booklet?... 3 What is an Intracranial Lesion?... 3 Who

More information

Dabigatran: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF

Dabigatran: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF Leeds Dabigatran: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF Amber Drug Level 3 (amber drug with monitoring requirements) We have started your

More information

What Is an Arteriovenous Malformation (AVM)?

What Is an Arteriovenous Malformation (AVM)? What Is an Arteriovenous Malformation (AVM)? From the Cerebrovascular Imaging and Intervention Committee of the American Heart Association Cardiovascular Council Randall T. Higashida, M.D., Chair 1 What

More information

X-Plain Trigeminal Neuralgia Reference Summary

X-Plain Trigeminal Neuralgia Reference Summary X-Plain Trigeminal Neuralgia Reference Summary Introduction Trigeminal neuralgia is a condition that affects about 40,000 patients in the US every year. Its treatment mostly involves the usage of oral

More information

MODERATE SEDATION RECORD (formerly termed Conscious Sedation)

MODERATE SEDATION RECORD (formerly termed Conscious Sedation) (POLICY #DOC-051) Page 1 of 6 WELLSPAN HEALTH - YORK HOSPITAL NURSING POLICY AND PROCEDURE Dates: Original Issue: September 1998 Annual Review: March 2012 Revised: March 2010 Submitted by: Brenda Artz

More information

Guide to Claims against General Practitioners (GPs)

Guide to Claims against General Practitioners (GPs) Patients often build up a relationship of trust with their GP over a number of years. It can be devastating when a GP fails in his or her duty to a patient. Our medical negligence solicitors understand

More information

Protocol for the safe administration of iodinated contrast media in diagnostic radiology

Protocol for the safe administration of iodinated contrast media in diagnostic radiology Protocol for the safe administration of iodinated contrast media in diagnostic radiology Protocol statement: This protocol applies to all staff within Radiology Departments at Heart of England NHS Foundation

More information

A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation

A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation PATIENT EDUCATION GUIDE What is atrial fibrillation? Atrial fibrillation

More information

Stroke Services. Maria Fitzpatrick Consultant Nurse

Stroke Services. Maria Fitzpatrick Consultant Nurse Stroke Services Maria Fitzpatrick Consultant Nurse WHO Definition: Stroke definition rapidly developing clinical signs of focal (at times global) disturbance of cerebral function, lasting more than 24

More information

PHENYLEPHRINE HYDROCHLORIDE INJECTION USP

PHENYLEPHRINE HYDROCHLORIDE INJECTION USP PRESCRIBING INFORMATION PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 10 mg/ml Sandoz Canada Inc. Date of Preparation: September 1992 145 Jules-Léger Date of Revision : January 13, 2011 Boucherville, QC, Canada

More information

The purpose of this course is to explain how to administer the NIH Stroke Scale, consistently and accurately.

The purpose of this course is to explain how to administer the NIH Stroke Scale, consistently and accurately. NIH Stroke Scale WWW.RN.ORG Reviewed December, 2015, Expires December, 2017 Provider Information and Specifics available on our Website Unauthorized Distribution Prohibited 2015 RN.ORG, S.A., RN.ORG, LLC

More information

Seven steps to patient safety The full reference guide. Second print August 2004

Seven steps to patient safety The full reference guide. Second print August 2004 Seven steps to patient safety The full reference guide Second print August 2004 National Patient Safety Agency Seven steps to patient safety 113 Appendix Four F Examples of events according to severity

More information

A4.7 Management of a totally occluded central catheter and persistent withdrawal occlusion (PWO)

A4.7 Management of a totally occluded central catheter and persistent withdrawal occlusion (PWO) A4.7 Management of a totally occluded central catheter and persistent withdrawal occlusion (PWO) Types of Catheter Related Thrombotic A catheter-related thrombus may be intraluminal (inside the catheter)

More information

Stuart B Black MD, FAAN Chief of Neurology Co-Medical Director: Neuroscience Center Baylor University Medical Center at Dallas

Stuart B Black MD, FAAN Chief of Neurology Co-Medical Director: Neuroscience Center Baylor University Medical Center at Dallas Billing and Coding in Neurology and Headache Stuart B Black MD, FAAN Chief of Neurology Co-Medical Director: Neuroscience Center Baylor University Medical Center at Dallas CPT Codes vs. ICD Codes Category

More information

Pathway for the management of DVT in primary Care

Pathway for the management of DVT in primary Care Pathway for the management of DVT in primary Care Final Version: Approved by NHS DGS CCG: June 2015 This document aims to support practices in DGS CCG in the Management & Treatment of patients with suspected

More information

Treatments to Restore Normal Rhythm

Treatments to Restore Normal Rhythm Treatments to Restore Normal Rhythm In many instances when AF causes significant symptoms or is negatively impacting a patient's health, the major goal of treatment is to restore normal rhythm and prevent

More information

SUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D]

SUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D] SUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D] I. Definitions: Detoxification is the process of interrupting the momentum of compulsive drug and/or alcohol use in an individual

More information

RENAL ANGIOMYOLIPOMA EMBOLIZATION

RENAL ANGIOMYOLIPOMA EMBOLIZATION RENAL ANGIOMYOLIPOMA EMBOLIZATION The information about renal angiomyolipomas on the next several pages includes questions commonly asked about the embolization procedure. Please take a few moments to

More information

CBT/OTEP 243 Aspirin Administration for ACS

CBT/OTEP 243 Aspirin Administration for ACS Seattle-King County EMS Seattle-King County Emergency Medical Services Division Public Health - Seattle/King County 401 5th Avenue, Suite 1200 Seattle, WA 98104 (206) 296-4693 February 2009 CBT/OTEP 243

More information

Treating your abdominal aortic aneurysm by open repair (surgery)

Treating your abdominal aortic aneurysm by open repair (surgery) Patient information Abdominal aortic aneurysm open surgery Treating your abdominal aortic aneurysm by open repair (surgery) Introduction This leaflet tells you about open repair of abdominal aortic aneurysm,

More information

Approximately 70-80% of all strokes are ischemic and 20-30% are hemorrhagic Hemorrhagic stroke is defined as an acute neurologic injury resulting from bleeding in the brain There are two distinct types

More information

REMINDER: Please ensure all stroke and TIA patients admitted to hospital are designated as "Stroke Service" in Cerner.

REMINDER: Please ensure all stroke and TIA patients admitted to hospital are designated as Stroke Service in Cerner. ACUTE STROKE CLINICAL PATHWAY QEH/HH PCH KCMH Souris Western Stewart Memorial O'Leary PATIENT ID INCLUSION CRITERIA* All patients admitted to hosptial with a suspected diagnosis of acute ischemic stroke

More information

Stroke An Overview. Dr Declan O Kane MD MRCP(UK) DipCompSci(Cantab) Consultant Physician VOL

Stroke An Overview. Dr Declan O Kane MD MRCP(UK) DipCompSci(Cantab) Consultant Physician VOL Stroke An Overview Dr Declan O Kane MD MRCP(UK) DipCompSci(Cantab) Consultant Physician VOL Stroke - Topics 1. Terminology 2. Prevention primary and secondary 3. Acute treatment 4. Stroke Units and Teams

More information

Guidelines and Protocols

Guidelines and Protocols TITLE: HEAD TRAUMA PURPOSE: To provide guidelines for rapid, accurate assessment of the head and intracranial structures for traumatic injury and to plan and implement appropriate interventions for identified

More information

Survey of Canadian Physicians Use of anti-thrombotic therapy for Atrial Fibrillation

Survey of Canadian Physicians Use of anti-thrombotic therapy for Atrial Fibrillation Survey of Canadian Physicians Use of anti-thrombotic therapy for Atrial Fibrillation On the following pages are a number of questions asking about the conditions under which you would prescribe anticoagulation

More information

Early Warning Scores (EWS) Clinical Sessions 2011 By Bhavin Doshi

Early Warning Scores (EWS) Clinical Sessions 2011 By Bhavin Doshi Early Warning Scores (EWS) Clinical Sessions 2011 By Bhavin Doshi What is EWS? After qualifying, junior doctors are expected to distinguish between the moderately sick patients who can be managed in the

More information

Treatment of Ischemic Stroke in the Neuro-ICU

Treatment of Ischemic Stroke in the Neuro-ICU Treatment of Ischemic Stroke in the Neuro-ICU Gary L. Bernardini, MD, PhD Professor of Neurology Director, Stroke and Neurocritical Care Departments of Neurology and Neurosurgery Albany Medical Center

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol

PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol PACKAGE LEAFLET: INFORMATION FOR THE USER PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion Paracetamol Read all of this leaflet carefully before you start using this medicine. Keep this leaflet.

More information